October 08, 2020

Regeneron Antibodies In Demand After Trump Treatment, Doctors Seek More Data-Reuters

Patients are asking to join clinical trials of antibody-based COVID-19 drugs after U.S. President Donald Trump was treated last week with an experimental therapy from Regeneron Pharmaceuticals Inc, and on Wednesday he promised to make it free to Americans while touting its benefits. Reuters, 10/07/2020